Signed in as:
filler@godaddy.com
Regulatory Strategy
Regulatory Insights
The right regulatory strategy, set early and revisited often, determines how quickly a therapy reaches patients and how much risk a sponsor carries along the way. Choosing the wrong pathway or walking into an agency meeting underprepared can cost a program months or years. PharmiOnyx provides regulatory strategy consulting built on experience across CROs, global pharma, and biotech, including direct work on small molecule and biologic submission strategy at CSL Behring, AbbVie, and Takeda.
We support sponsors in evaluating regulatory options and preparing for agency interactions, working alongside your internal regulatory affairs team and regulatory counsel rather than in place of them.
Our Regulatory Strategy services include:
Regulatory Pathway Assessment
We evaluate available regulatory pathways, including standard, accelerated, breakthrough, and orphan designations, and provide guidance on the pathway that best fits the molecule, the data package, and the development timeline.
Agency Meeting Preparation Support
We support preparation for pre-IND, End of Phase 2, Type B and Type C, and other FDA and EMA meetings, including briefing document development, anticipated question preparation, and mock meeting sessions to help the sponsor's team pressure test their position before the meeting.
Submission Strategy Consulting
We help develop the overall strategy and timeline for IND, NDA, BLA, and MAA submissions, advising on content sequencing across functions so the submission comes together coherently.
Module Content Development Support
We support authoring and review of submission content beyond CMC, including nonclinical and clinical summary sections, helping ensure the full submission tells one consistent scientific story.
Global Regulatory Strategy Consulting
We help reconcile regulatory requirements across FDA, EMA, and other major health authorities, supporting sponsors running multi-region development and submission programs.
Labeling Strategy Support
We provide input into labeling strategy development, helping ensure proposed labeling claims are supported by the underlying data package.
Lifecycle Regulatory Planning Support
We support post-approval regulatory planning, including variation and supplement strategy considerations, so organizations can manage change without disrupting market access.
Who we work with: biotech sponsors preparing for a first regulatory agency meeting who want an experienced consulting partner to help their team get ready, and pharma organizations running multi-region submissions who need consulting support to coordinate a coherent global regulatory strategy.
PharmiOnyx provides scientific and strategic consulting and does not serve as the sponsor's regulatory agent of record.
